Skip to contentO
Odyssey Health, Inc.
O
ODYYOdyssey Health, Inc. Q3 2023 · 10-Q
Revenue—
Net Income-$1.28M-$1.28MN/M vs Q3 2022 EPS Diluted-$0.02-$0.02N/M vs Q3 2022 Operating Income-$1,094,610N/M Operating Cash Flowderived-$166,248N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Odyssey Health, Inc. · CIK 1626644 · Engraved from SEC EDGAR
ended Apr 30, 2023 · filed Jun 14, 2023 · 45 d after period end